Back to search

Ireland· IE-PA-EU/1/07/413/1-3

Gliolan 30 mg/ml powder for oral solution

A aminolevulinic acid product containing 5-aminolevulinic acid hydrochloride, registered in Ireland by Photonamic GmbH & Co. KG. The same ATC class is registered in 14 of our 19 countries.

ATC L01XD04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedGliolan 30 mg/ml powder for oral solu…ATCL01XD04REGISTER NO.IE-PA-EU/1/07/413/1-3PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Aminolevulinic acid is registered in 14 of 19 countries.

Countries holding a registration under ATC L01XD04 (aminolevulinic acid), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Aminolevulinic acid · ATC L01XD04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
5-aminolevulinic acid hydrochloride
Manufacturer
Photonamic GmbH & Co. KG
Country
Ireland (IE)
ATC code
L01XD04
ATC class
Aminolevulinic acid
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/07/413/1-3

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

121 interactions on record for aminolevulinic acid.

Graded by severity as the source publishes them — 120 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Aminolevulinic acid · interactions on record

121 records

  • 120 severe
  • 1 moderate

Most severe, free to view

  • MinocyclineA01AB23severe
  • SulfasalazineA07EC01severe
  • GlibenclamideA10BB01severe
  • ChlorpropamideA10BB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aminolevulinic acid in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aminolevulinic acid products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Alacare
  • Belgium · Effala
  • Czechia · Alacare
  • Germany · Alacare
  • Denmark · Alacare
  • Finland · Alacare
  • France · Effala
  • United Kingdom (Northern Ireland) · Alacare
  • Iceland · Ameluz, Gliolan
  • Italy · Alacare
  • Liechtenstein · Ameluz, Gliolan
  • Netherlands · Alacare
  • Norway · Alacare, Ameluz
  • Poland · Alacare
  • Portugal · Alacare
  • Sweden · Alacare
  • Slovakia · Alacare

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e791377d-064f-4181-8557-3d9463c0223b
GET /v1/drugs/e791377d-064f-4181-8557-3d9463c0223b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for oral solution",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01XD",
    "L01XD04"
  ],
  "strength": null,
  "pa_number": "EU/1/07/413/1-3",
  "substances": [
    "5-aminolevulinic acid hydrochloride"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "07/09/2007",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about aminolevulinic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.